An adeno-associated virus vector carrying MG53 gene that can alleviate the symptoms of heart failure in mice
A viral vector and virus technology, applied in the field of construction and evaluation of therapeutic effects, can solve the problems of weak targeting and low transduction efficiency.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0048] Example 1 Construction of 293 cell line stably and highly expressing MG53 gene
[0049] The 293 cell line with stable and high expression of MG53 gene was constructed by adeno-associated virus vector.
[0050] 1 Experimental materials
[0051] Reagent name
Manufacturer
Escherichia coli strain DH5α
Tiangen
restriction endonuclease
Fermentas
T4 ligase
Fermentas
Plasmid DNA Small, Massive Extraction Kit
Kang Wei Century
Gel Recovery Kit
Axygen
[0052] Agarose
Biowest
DNA ladder
GeneRay
[0053] Carrier and target gene information
[0054] 1) The pHBAAV-CMV-IRES-Zsgreen vector map is as follows figure 1 Shown, wherein EcoRI and BamHI are insertion sites, and its sequence is shown in SEQ ID NO.:3.
[0055] The pHBAAV-CMV-IRES-Zsgreen vector has a CMV promoter to promote the expression of the target gene, and contains the Zsgreen gene as a marker.
[0056] 2) The polyn...
Embodiment 2
[0070] Example 2 Adeno-associated virus packaging
[0071] 1. Experimental process
[0072] The adeno-associated virus shuttle plasmid and its auxiliary packaging original vector plasmid were prepared. The three plasmid vectors were extracted with high purity and no endotoxin, and co-transfected into AAV-293 cells. After 8 hours of transfection, they were replaced with complete medium, and after 48 hours of culture, The cell supernatant rich in adeno-associated virus particles was collected, the virus supernatant was filtered with a 0.45um filter (Millpore Company), and the virus supernatant was concentrated by ultracentrifugation. After it is concentrated, a high-titer adeno-associated virus concentrate is obtained.
[0073] 2. Experimental materials
[0074] 2.1 Adeno-associated virus vectors, packaging cells and strains
[0075] The viral packaging system is a three-plasmid system consisting of RC (the plasmid sequence is shown in SEQ ID NO.: 6), pHelper (the plasmid seq...
Embodiment 3
[0097] Example 3 Injection of adeno-associated virus with high expression of MG53 into heart failure model mice improves the symptoms of heart failure in mice
[0098] 1. Experimental materials
[0099] C57BL / 6 mice (the plasmid can be purchased from Shanghai Slack Experimental Animal Co., Ltd.).
[0100] 2. Experimental method
[0101] 2.1 Modeling of heart failure in mice
[0102] The right anterior external incision was taken to open the chest, and the ascending aorta was exposed, and the ascending aorta was constricted with a constriction ring at 1 cm above the aorta, and the heart failure of the mice could be induced after 4 weeks.
[0103] 2.2 Tail vein injection of pHBAAV-CMV-IRES-Zsgreen-MG53 and control adeno-associated virus
[0104] Using a 5-gauge needle syringe, inject 1x10 per mouse 11 The adeno-associated virus of v.g, the control adeno-associated virus is AAV-GFP (adeno-associated virus with green fluorescent protein).
[0105] 2. Experimental results
[...
PUM
| Property | Measurement | Unit |
|---|---|---|
| diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More - R&D
- Intellectual Property
- Life Sciences
- Materials
- Tech Scout
- Unparalleled Data Quality
- Higher Quality Content
- 60% Fewer Hallucinations
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2025 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com



